Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nortriptyline-Topiramate Stepwise Regimen for Meniere's Disease
NCT05582837Phase 4Recruiting
- Sponsor
- University of California, Irvine
- Start
- Aug 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nortriptyline, topiramate in Meniere's disease (MD), sponsored by University of California, Irvine. Started Aug 2022; status: recruiting.
02
Drugs
nortriptylinetopiramate
03
Conditions
Meniere's disease (MD)
Beyond the preview
Go deeper on NCT05582837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05582837.